Search Results 2491-2500 of 26013 for Pulmonary
The purpose of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over ...
Venous thrombotic events (e.g., deep vein thrombosis) or pulmonary arterial events (e.g., pulmonary embolism) within 1 month before the first dose of study drug ...
... pulmonary vasodilators. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Documentation of pulmonary thromboembolism in the last 12 months 9. Cardiovascular co-morbidities 10. Receipt of any approved pulmonary arterial ...
Estimated pulmonary artery systolic pressure (PASP) > 70 mm Hg assessed by site based on echocardiography or right heart catheterization, unless active ...
... Pulmonary Rehabilitation. 2022 - present. MentorCardioNerds Academy Scholars Program. 2022 - present. MemberAmerican Association of Cardiovascular and Pulmonary ...
Most peripheral pulmonary lesions are benign, yet the malignant minority represent the leading cause of cancer death for both men and women. A five-year ...
Pulmonary pathology; Autopsy pathology. Mayo Clinic locations. Rochester, Minnesota. Driving directions. More info. Billing & insurance · Accessibility ...
Pulmonary artery branch diameter ≥ 7mm - (implant target artery - assessed during the right heart catheterization). Exclusion Criteria: Active infection ...
A Study Of 4D Virtual Catheter (4D VCath) For Multi-Factorial Hemodynamics In Pulmonary Hypertension · Overview · Participation eligibility · Participating Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.